Literature DB >> 23214407

Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors.

Kohei Sano1, Takahito Nakajima, Peter L Choyke, Hisataka Kobayashi.   

Abstract

A major barrier to cancer treatment is the inability to deliver sufficient concentrations of drug to the tumor without incurring systemic toxicities. Nanomaterials are appealing because they can carry a large drug payload; however, tumor delivery is limited by modest leakage and retention in most tumors. We observed that after photoimmunotherapy (PIT), which is a light-mediated treatment based on an antibody-photosensitizer conjugate, there was surprisingly high leakage of nanosized (10-200 nm) agents into the tumor bed. PIT rapidly induced death in perivascular cancer cells, leading to immediate and dramatic increases in vascular permeability, resulting in up to 24-fold greater accumulation of nanomaterials within the PIT-treated tumor compared with controls, an effect termed "super-enhanced permeability and retention". In a treatment study, PIT followed by liposome-containing daunorubicin, DaunoXome (diameter 50 nm), resulted in greater survival in tumor-bearing mice than either PIT or DaunoXome alone. Thus, PIT greatly enhances delivery of nanosized reagents and thus holds promise to improve therapeutic responses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23214407      PMCID: PMC3586604          DOI: 10.1021/nn305011p

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  26 in total

Review 1.  Macromolecular therapeutics in cancer treatment: the EPR effect and beyond.

Authors:  Hiroshi Maeda
Journal:  J Control Release       Date:  2012-05-01       Impact factor: 9.776

Review 2.  Nano-sized MRI contrast agents with dendrimer cores.

Authors:  Hisataka Kobayashi; Martin W Brechbiel
Journal:  Adv Drug Deliv Rev       Date:  2005-11-10       Impact factor: 15.470

3.  Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy.

Authors:  Adam J Gormley; Nate Larson; Shraddha Sadekar; Ryan Robinson; Abhijit Ray; Hamidreza Ghandehari
Journal:  Nano Today       Date:  2012-05-24       Impact factor: 20.722

Review 4.  Early intervention in cancer using monoclonal antibodies and other biological ligands: micropharmacology and the "binding site barrier".

Authors:  J N Weinstein; W van Osdol
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

Review 5.  Drug penetration in solid tumours.

Authors:  Andrew I Minchinton; Ian F Tannock
Journal:  Nat Rev Cancer       Date:  2006-08       Impact factor: 60.716

6.  Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma.

Authors:  C A Presant; M Scolaro; P Kennedy; D W Blayney; B Flanagan; J Lisak; J Presant
Journal:  Lancet       Date:  1993-05-15       Impact factor: 79.321

7.  Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes.

Authors:  J Vaage; D Donovan; E Mayhew; R Abra; A Huang
Journal:  Cancer       Date:  1993-12-15       Impact factor: 6.860

8.  A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II.

Authors:  M Suzuki; K Hori; I Abe; S Saito; H Sato
Journal:  J Natl Cancer Inst       Date:  1981-09       Impact factor: 13.506

Review 9.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

10.  Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules.

Authors:  Makoto Mitsunaga; Mikako Ogawa; Nobuyuki Kosaka; Lauren T Rosenblum; Peter L Choyke; Hisataka Kobayashi
Journal:  Nat Med       Date:  2011-11-06       Impact factor: 53.440

View more
  97 in total

1.  Porphyrin-lipid stabilized paclitaxel nanoemulsion for combined photodynamic therapy and chemotherapy.

Authors:  Enling Chang; Jiachuan Bu; Lili Ding; Jenny W H Lou; Michael S Valic; Miffy H Y Cheng; Véronique Rosilio; Juan Chen; Gang Zheng
Journal:  J Nanobiotechnology       Date:  2021-05-25       Impact factor: 10.435

2.  Mild hyperthermia enhances transport of liposomal gemcitabine and improves in vivo therapeutic response.

Authors:  Dickson K Kirui; Christian Celia; Roberto Molinaro; Shyam S Bansal; Donato Cosco; Massimo Fresta; Haifa Shen; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2015-02-26       Impact factor: 9.933

3.  Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer.

Authors:  Kimihiro Ito; Makoto Mitsunaga; Takashi Nishimura; Masayuki Saruta; Takeo Iwamoto; Hisataka Kobayashi; Hisao Tajiri
Journal:  Bioconjug Chem       Date:  2017-04-26       Impact factor: 4.774

Review 4.  Stimuli-responsive liposomes for drug delivery.

Authors:  Y Lee; D H Thompson
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-15

5.  Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer.

Authors:  Yuko Nakamura; Zoe Weaver Ohler; Deborah Householder; Tadanobu Nagaya; Kazuhide Sato; Shuhei Okuyama; Fusa Ogata; Dagane Daar; Tieu Hoa; Peter L Choyke; Hisataka Kobayashi
Journal:  Mol Cancer Ther       Date:  2016-11-15       Impact factor: 6.261

6.  Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT).

Authors:  Tadanobu Nagaya; Yuko Nakamura; Kazuhide Sato; Toshiko Harada; Peter L Choyke; Hisataka Kobayashi
Journal:  J Control Release       Date:  2016-04-05       Impact factor: 9.776

7.  Near infrared photoimmunotherapy for lung metastases.

Authors:  Kazuhide Sato; Tadanobu Nagaya; Makoto Mitsunaga; Peter L Choyke; Hisataka Kobayashi
Journal:  Cancer Lett       Date:  2015-05-27       Impact factor: 8.679

Review 8.  Tumor targeting via EPR: Strategies to enhance patient responses.

Authors:  Susanne K Golombek; Jan-Niklas May; Benjamin Theek; Lia Appold; Natascha Drude; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2018-07-19       Impact factor: 15.470

9.  Encapsulation of a nitric oxide donor into a liposome to boost the enhanced permeation and retention (EPR) effect.

Authors:  Yu Tahara; Takuma Yoshikawa; Hikari Sato; Yukina Mori; Md Hosain Zahangir; Akihiro Kishimura; Takeshi Mori; Yoshiki Katayama
Journal:  Medchemcomm       Date:  2016-12-21       Impact factor: 3.597

10.  Real-time monitoring of hemodynamic changes in tumor vessels during photoimmunotherapy using optical coherence tomography.

Authors:  Chia-Pin Liang; Takahito Nakajima; Rira Watanabe; Kazuhide Sato; Peter L Choyke; Yu Chen; Hisataka Kobayashi
Journal:  J Biomed Opt       Date:  2014-09       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.